A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MAC SEC filings page.
The Macerich Company (MAC) reported $1.0B in revenue over the twelve months to Sep 30, 2026, down 1.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The business produces operating cash despite recurring losses, while revenue growth has coincided with heavier debt financing and shrinking equity.
From FY2023 to FY2025, revenue rose14.7% while operating cash flow rose only8.8% , showing that growth did not translate into proportionate cash expansion. Long-term debt climbed22.6% over that span, while FY2025 liabilities reached69.8% of assets, making balance-sheet financing more prominent.
FY2025's net loss was
FY2025 dividends paid were
Financial Health Signals
Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of The Macerich Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
FFO Margin measures funds from operations against revenue, and funds from operations here is net income with all depreciation and amortization and real estate impairments added back and gains on property sales taken out, since a building written down a little further every year on paper is often worth more rather than less. The Macerich Company scores 60/100 on it among other REITs.
FFO Growth follows the three-year path of funds from operations, which here is net income with all depreciation and amortization and real estate impairments added back and gains on property sales taken out. The Macerich Company scores 78/100 on it among other REITs.
Not available for The Macerich Company, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Not available for The Macerich Company, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. The Macerich Company scores 64/100 on it among other REITs.
Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. The Macerich Company scores 83/100 on it among other REITs.
The Macerich Company passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.
The Macerich Company reported a net loss of $197.1M while generating $321.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
The Macerich Company generated $260.1M in revenue in Q3 2026. This represents an increase of 2.7% from the same quarter a year earlier. Against the prior quarter it is up 4.1%.
The Macerich Company reported a net loss of $16.7M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
The Macerich Company earned -$0.06 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2026.
Cash & Balance Sheet
The Macerich Company held $560.8M in cash against $4.4B in long-term debt as of Q3 2026.
The Macerich Company paid $0.17 per share in dividends in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q3 2026.
Margins & Returns
The Macerich Company's net profit margin was -6.4% in Q3 2026, showing the share of revenue converted to profit. This is up 28.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.4 percentage points.
The Macerich Company's quarterly ROE was -0.6% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
MAC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $260.1M+2.7% | $249.7M0.0% | $241.5M-3.1% | $261.7M-4.4% | $253.3M+15.0% | $249.8M+15.9% | $249.2M+19.4% | $273.7M+14.7% |
| SG&A Expenses | $8.5M+23.3% | $9.5M+21.7% | $8.0M+5.4% | $9.2M+22.7% | $6.9M+15.3% | $7.8M+11.5% | $7.6M-0.4% | $7.5M-0.7% |
| Income Tax | $80Kn/m | $495Kn/m | -$2.6Mn/m | -$473Kn/m | -$710K-230.3% | -$188K-172.9% | -$822Kn/m | -$879Kn/m |
| Net Income | -$16.7Mn/m | -$27.1Mn/m | -$36.4Mn/m | -$18.8Mn/m | -$87.4Mn/m | -$40.9M-116.2% | -$50.1Mn/m | -$211.2M-439.7% |
| EPS (Basic) | -$0.06n/m | -$0.10n/m | -$0.14n/m | -$0.07n/m | -$0.34n/m | -$0.16-113.8% | -$0.20n/m | -$0.96-442.9% |
| EPS (Diluted) | -$0.06n/m | -$0.10n/m | -$0.14n/m | -$0.07n/m | -$0.34n/m | -$0.16-113.8% | -$0.20n/m | -$0.96-442.9% |
| Diluted Shares (Avg) | 284M+11.8% | 274M+8.2% | 258M+2.0% | N/A | 254M+16.3% | 253M+17.1% | 253M+17.1% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Interest Expense.
MAC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.8B+4.1% | $8.5B-2.4% | $8.2B-5.6% | $8.4B-2.3% | $8.4B+11.0% | $8.7B+12.2% | $8.7B+17.9% | $8.6B+14.0% |
| Cash & Equivalents | $560.8M+93.3% | $227.0M+73.2% | $182.0M-28.1% | $280.2M+211.9% | $290.2M+149.1% | $131.1M+85.4% | $253.2M+110.9% | $89.9M-5.3% |
| Total Liabilities | $6.0B+2.1% | $5.6B-7.4% | $5.7B-4.3% | $5.8B+2.0% | $5.8B+16.8% | $6.1B+16.9% | $5.9B+18.7% | $5.7B+14.8% |
| Long-Term Debt | $4.4B-13.1% | $4.8B-7.3% | $4.9B-7.3% | $5.1B+3.6% | $5.1B+16.9% | $5.2B+19.6% | $5.2B+27.7% | $4.9B+18.3% |
| Total Equity | $2.7B+8.5% | $2.8B+9.4% | $2.4B-8.5% | $2.4B-11.2% | $2.5B0.0% | $2.6B+3.2% | $2.7B+16.5% | $2.8B+12.6% |
| Retained Earnings | -$4.0Bn/m | -$3.9Bn/m | -$3.9Bn/m | -$3.8Bn/m | -$3.7Bn/m | -$3.6Bn/m | -$3.5Bn/m | -$3.4Bn/m |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.
MAC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $109.4M-2.7% | $66.9M-5.2% | $77.4M-12.6% | $50.2M-8.5% | $112.4M+12.3% | $70.5M+4.6% | $88.5M+44.8% | $54.9M+11.1% |
| Depreciation & Amortization | $91.4M-2.8% | $89.2M-2.2% | $86.0M-9.7% | $87.7M+4.2% | $94.0M+23.8% | $91.2M+22.6% | $95.2M+33.4% | $84.2M+15.8% |
| Stock-Based Compensation | $6.5M+33.7% | $6.8M+32.1% | $5.9M+84.1% | N/A | $4.9M+26.6% | $5.1M+114.4% | $3.2M+17.4% | N/A |
| Investing Cash Flow | -$71.5Mn/m | -$338.1Mn/m | -$54.7Mn/m | -$7.2M-119.3% | -$3.5M-105.3% | -$231.6Mn/m | -$83.0Mn/m | $37.2M+83.7% |
| Financing Cash Flow | $274.3M+493.2% | $311.4M+640.2% | -$124.9M-177.3% | -$50.7Mn/m | $46.2Mn/m | $42.1Mn/m | $161.6M+24124.6% | -$144.5Mn/m |
| Dividends Paid | $51.1M+11.5% | $51.8M+13.3% | $49.0M-2.8% | $46.2M+12.0% | $45.9M+15.1% | $45.7M+11.5% | $50.4M+28.7% | $41.2M+5.3% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.
MAC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Net Margin | -6.4%+28.1pp | -10.8%+5.5pp | -15.0%+5.1pp | -7.2%+70.0pp | -34.5%+14.6pp | -16.4% | -20.1%+40.6pp | -77.2%-103.2pp |
| Return on Equity | -0.6%+2.9pp | -1.0%+0.6pp | -1.5%+0.4pp | -0.8%+6.9pp | -3.5%+0.8pp | -1.6%-11.6pp | -1.9%+3.7pp | -7.7%-10.2pp |
| Return on Assets | -0.2%+0.8pp | -0.3%+0.1pp | -0.4%+0.1pp | -0.2%+2.3pp | -1.0%+0.4pp | -0.5%-3.7pp | -0.6%+1.1pp | -2.5%-3.3pp |
| Debt-to-Equity | 1.62-0.4x | 1.71-0.3x | 1.990.0x | 2.07+0.3x | 2.02+0.3x | 2.02+0.3x | 1.96+0.2x | 1.78+0.1x |
| Liabilities-to-Equity | 2.19-0.1x | 1.99-0.4x | 2.33+0.1x | 2.39+0.3x | 2.33+0.3x | 2.35+0.3x | 2.230.0x | 2.080.0x |
| Asset Turnover | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| The Macerich Company MAC | FY2025 | $1.0B | -$197.1M | -19.4% | $6.6B | 71/100 |
| NNN REIT, Inc. NNN | FY2025 | $926.2M | $389.8M | 42.1% | $7.8B | 75/100 |
| Essential Properties Realty Trust, Inc. EPRT | FY2025 | $561.2M | $253.0M | 45.1% | $6.2B | 79/100 |
| Kite Realty Group Trust KRG | FY2025 | $844.4M | $298.7M | 35.4% | $4.9B | 53/100 |
| Brixmor Property Group Inc. BRX | FY2025 | $1.4B | $386.2M | 28.2% | $9.3B | 67/100 |
| Phillips Edison & Company, Inc. PECO | FY2025 | $726.6M | $111.3M | 15.3% | $5.2B | 68/100 |
Where The Macerich Company Ranks
Frequently Asked Questions
The Macerich Company (MAC) reported $1.0B in total revenue for fiscal year 2025. This represents a 10.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
The Macerich Company (MAC) revenue grew by 10.4% year-over-year, from $918.2M to $1.0B in fiscal year 2025.
No, The Macerich Company (MAC) reported a net loss of $98.9M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $197.1M, with a net profit margin of -19.4%.
As of fiscal year 2025, The Macerich Company (MAC) had $280.2M in cash and equivalents against $5.1B in long-term debt.
The Macerich Company (MAC) had a net profit margin of -19.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, The Macerich Company (MAC) paid $0.68 per share in dividends during fiscal year 2025.
The Macerich Company (MAC) has a return on equity of -8.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
The Macerich Company (MAC) generated $321.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
The Macerich Company (MAC) had $8.4B in total assets as of fiscal year 2025, including both current and long-term assets.
The Macerich Company (MAC) had a debt-to-equity ratio of 2.07 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
The Macerich Company (MAC) had a liabilities-to-equity ratio of 2.39 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
The Macerich Company (MAC) had a return on assets of -2.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
The Macerich Company (MAC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $6.6B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
The Macerich Company (MAC) trades at 6.5x sales, its market capitalization divided by $1.0B revenue, trailing 12 months to September 30, 2026. The market capitalization is $6.6B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
The Macerich Company (MAC) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
The Macerich Company (MAC) reported a net loss of $197.1M while generating $321.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
The Macerich Company (MAC) scores 71 out of 100 on our Financial Health Score, indicating strong standing within its REITs peer group. The score is the average of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For The Macerich Company it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.